- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia (CLL), +20 more
- Locations
-
- Medizinische Universität Innsbruck Innsbruck, Tyrolia, Austria
- Medizinische Universität Graz Graz, Austria
- BKH Kufstein Kufstein, Austria
- Onkologischer Schwerpunkt am Oskar-Helene-Heim Berlin, Germany
Clinical trial condition
Chronic Lymphocytic Leukaemia (CLL)
Explore clinical trials studying Chronic Lymphocytic Leukaemia (CLL). Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Chronic Lymphocytic Leukaemia (CLL) trial results
Enrolling by Invitation
Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.
NCT06762431
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukaemia (CLL), Disease Attributes, +15 more
- Locations
-
- Hematology/Oncology department Vitebsk, Select A State, Belarus
NCT02920697
- Conditions
- B-Cell Non-Hodgkin Lymphoma (NHL), Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services Melbourne, Australia
- Hopital Claude Huriez Lille, France
- CHU de Nantes Nantes, France
- Centre hospitalier Lyon Sud Pierre-Bénite, France
Completed
CLL Empirical Antibiotic Regimen
NCT01279252
- Conditions
- Chronic Lymphocytic Leukaemia (CLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- King's College Hospital NHS Foundation Trust London, United Kingdom
Active, Not Recruiting
Retention Rate of Acalabrutinib in a Non-interventional Setting
NCT05645172
- Conditions
- Chronic Lymphocytic Leukaemia (CLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Research Site D Ren, Germany
- Research Site Herrsching am Ammersee, Germany
- Research Site L Rrach, Germany
- Research Site M Nchen, Germany